Abdullah bin Zayed Honors Winners of the Al Hassan Bin Ali Award 2017 as Part of the Fourth Annual Forum for Promoting Peace in Muslim Societies
His Highness Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation, hosted a ceremony to honor the ‘Egyptian Family House’, winner of the Imam Al Hassan bin Ali Award 2017, represented by Dr. Mahmoud Hamdi Zaqzouq, Secretary General, and His Eminence Anba Ermia, Assistant Secretary General. Also present were H.E Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and H.E Shaykh Abdallah Bin Bayyah, President of the Forum for Promoting Peace in Muslim Societies.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171214005883/en/
Left to right: H.E Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance, H.H Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation, H.E Shaykh Abdallah Bin Bayyah, President of the Forum for Promoting Peace in Muslim Societies, His Eminence Anba Ermia, Assistant Secretary General and Dr. Mahmoud Hamdi Zaqzouq, Secretary General (Photo: AETOSWire)
In his address at the ceremony, which was attended by a large crowd of scholars, intellectuals and representatives of various faiths, taking part in the fourth annual Forum for Promoting Peace in Muslim Societies in Abu Dhabi, H.E Shaykh Abdallah Bin Bayyah commended the award, the first-of-its-kind in the Islamic world. He also thanked His Highness Sheikh Abdullah bin Zayed Al Nahyan, for his kind patronage of the award, which receives full support from His Highness Sheikh Khalifa bin Zayed Al Nahyan, President of the UAE, H.H Sheikh Mohammad bin Rashid Al Maktoum, UAE Vice President, Prime Minister and Ruler of Dubai, and H.H Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, Deputy Commander General of the UAE Armed Forces.
He said: "The award reflects the culture of tolerance, peace and harmony established by the founding leader, late Sheikh Zayed. It epitomizes an important stage in our long and noble history... the timeless story of Imam Hassan bin Ali, who endeavored to bring peace between two warring factions of Muslims, and managed to avert a bloody confrontation. The award was named in memory of this great man, who embodies peace and coexistence, but many Muslims disregard this fact.”
He noted that the forum has decided to present the 2017 ‘Imam Al Hassan Bin Ali Award for Promoting Peace’ to an entity established by the Grand Sheikh of al-Azhar, Ahmed al-Tayeb, and the now deceased Coptic Orthodox Pope Shenouda, the "Egyptian Family House," in recognition of its valuable role in achieving unity between Egyptians, uprooting sectarian hatred and promoting the values of tolerance and coexistence.
After receiving the award, Dr. Mahmoud Hamdi Zaqzouq, Secretary General of the ‘Egyptian Family House’ extended his thanks to the UAE and its leaders, who are following in the footsteps of Zayed Al Khair; and thanked Shaykh Abdallah Bin Bayyah for his significant role within the Forum. He expressed his delight to receive this privilege, which recognizes the noble meanings and ethics advocated by all religions. He pointed out that the Egyptian Family House represents the brotherhood and unity that brings together Muslims and Christians who live together in love and harmony in the different parts of Egypt.
He also cited Quranic verse: “Whether they are the ones who believe, or whether they are Jews, Christians or Sabians – all who believe in Allah and the Last Day, and do righteous deeds – their reward is surely secure with their Lord; they need have no fear, nor shall they grieve,” to say that faith and good deeds are the common thing that bind us all and that God Almighty is the only judge of people’s faith or disbelief.
Dr. Zaqzouq also referred to the verse: “O mankind, indeed we have created you from male and female and made you peoples and tribes that you may know one another”, which calls for interaction and cooperation, and guides unity between Muslims and Christians. In conclusion, he reiterated his thanks to the sponsors of the award, who are following in the footsteps of H.H late Sheikh Zayed bin Sultan Al Nahyan, the founding father; and wished the forum further success for the benefit of all.
"We are gathered here today in the land of generosity, the home of the late Sheikh Zayed bin Sultan Al Nahyan, and under the patronage of the sons of Zayed Al Khair, in a spirit of love and harmony, guided by the verses on peace glorified in both the Quran and the Bible,” said Anba Ermia, Assistant Secretary General of the Egyptian Family House.
He expressed his pride in the Forum for Promoting Peace in Muslim Societies and its valuable role in promoting peace and tolerance under the patronage of H.H Sheikh Khalifa Bin Zayed Al Nahyan, President of the UAE; H.H Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President, Prime Minister and Ruler of Dubai; H.H Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces. He also thanked H.H Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation, patron of the forum; H.E Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance; and H.E Shaykh Abdullah bin Bayyah.
“Ladies and Gentlemen, we are gathered here in the Land of Tolerance, as part of the Forum for Promoting Peace, to curb and prevent terrorism,” he added. He referred to the variety of verses in the Quran and the Bible, which celebrate human beings, and evoked the Pact of Umar, who refused to pray in the Church of the Holy Sepulcher; a gesture which embodies his consideration of other faiths.
“These are significant examples of coexistence that we need to emulate, to contribute positively in building humans and ensuring prosperity and construction. Examples of coexistence between the different religious beliefs, while preserving the characteristics of each faith,” he concluded.
About the Winner
The ‘Egyptian Family House’ is an initiative that represents a model of religious coexistence. Established in 2011 by the post-revolutionary cabinet of Essam Sharaf, the Egyptian Family House was first conceived by the Grand Sheikh of al-Azhar, Ahmed al-Tayeb, and the now-deceased Coptic Orthodox Pope Shenouda of Alexandria. Headquartered in Cairo, the Egyptian Family House consists of Muslim scholars, clerics from the Coptic Church, representatives of various Christian faiths in Egypt, and a number of Egyptian intellectuals.
The ‘Egyptian Family House’ aims to preserve the fabric of Muslim-Christian unity within the Egyptian society, by following a number of means to achieve this end; notably, reaffirming the noble values and common characteristics between the various religions and cultures; establishing a new discourse that caters to the needs of the youth, as a pillar to moral and education, to encourage peace, and the rejection of hatred and violence; promoting cooperation and coexistence among citizens; monitoring and proposing preventive means to maintain social peace; and training imams and priests in various parts of the country to acquaint followers with other faiths to maintain social peace.
To read more news releases about the Fourth Annual Forum for Promoting Peace in Muslim Societies, please follow this link: http://aetoswire.com//newsroom/1/forum-for-promoting-peace-in-muslim-societies
Forum for Promoting Peace in Muslim Societies
Amani Mohamed, Media Office, 00971503366878
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 11:54 | Pressemelding
Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr
Schlumberger Announces Third-Quarter 2018 Results19.10.2018 11:00 | Pressemelding
Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third
Tradeshift Announces Q3 2018 Results19.10.2018 11:00 | Pressemelding
Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between
Alibaba’s Robust Ecosystem Supercharges 2018 11.11 Global Shopping Festival19.10.2018 10:15 | Pressemelding
Alibaba Group Holding Limited (NYSE:BABA) today officially kicked off the 2018 11.11 Global Shopping Festival in China’s capital, promising this year’s mega-event will be the largest-ever in terms of scale and reach. Businesses within the Alibaba ecosystem will jointly offer hundreds of millions of consumers an enriching experience that supports their pursuit of high-quality products, entertainment and fast, reliable services. The Festival will also demonstrate the enthusiasm of consumers and brands embracing Alibaba’s New Retail strategy – the convergence of online and offline retail through technology. “This year marks the 10th anniversary of 11.11. On the back of China’s explosive digital transformation, the Festival’s astounding growth over the past decade has powered the steady growth of quality consumption sought by Chinese shoppers. The evolution also showcases the development of the Alibaba ecosystem over time expanding well beyond e-commerce,” said Alibaba Group CEO Daniel Zha
Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC19.10.2018 10:08 | Pressemelding
Boehringer Ingelheim today announced results from GioTag, a real-world retrospective study which examined the impact of first-line Giotrif®/Gilotrif® (afatinib) followed by osimertinib, in epidermal growth factor receptor mutation-positive (EGFR M+) non-small cell lung cancer (NSCLC) patients with acquired T790M mutations, the most common mechanism of resistance to first- and second-generation EGFR tyrosine kinase inhibitors (TKIs). The results showed that the sequential strategy was effective in delaying subsequent chemotherapy treatment and were published today in the journal Future Oncology. According to the study, the median time on treatment for sequential afatinib and osimertinib was 27.6 months. In this broad, real-world population, the clinical benefit was consistent across all patient subgroups, with particularly encouraging results seen in those with exon 19 deletion (Del19)-positive disease (median time on treatment 30.3 months) and Asian patients (median time on treatment 4
Clovis Oncology Presents Initial Results from the Ongoing Rubraca® (rucaparib) TRITON Program in Metastatic Castration Resistant Prostate Cancer (mCRPC) at ESMO 2018 Congress19.10.2018 10:01 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced initial data from its ongoing Phase 2 TRITON2 clinical trial of Rubraca at the ESMO 2018 Congress (European Society for Medical Oncology). The data show a 44% confirmed objective response rate (ORR) by investigator assessment in 25 RECIST* /PCWG3** response-evaluable patients with a BRCA1/2 alteration. The median duration of response in these patients has not yet been reached. In addition, a 51% confirmed prostate specific antigen (PSA) response rate was observed in 45 PSA response-evaluable patients with a BRCA1/2 alteration. The TRITON2 results were the basis for Breakthrough Therapy designation for Rubraca as a monotherapy treatment of adult patients with BRCA1/2 mutated mCRPC who have received at least one prior androgen receptor (AR)-directed therapy and taxane-based chemotherapy, which was granted on October 2, 2018 by the U.S. Food and Drug Administration (FDA). These data will be highlighted in a poster authored by Dr. Wassim